Validation of Edema-invariant Multi-shell High Angular Resolution Diffusion Imaging (msHARDI)-Based Tractography With Intra-operative Cortical Stimulation
Sponsor: Abramson Cancer Center at Penn Medicine
Listed as NCT02559401, this observational or N/A phase trial focuses on Brain Lesions and remains completed. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 13 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2023 — May 2023 [monthly]
Active Not Recruiting
-
Mar 2022 — Apr 2023 [monthly]
Active Not Recruiting
▶ Show 8 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting
-
Apr 2020 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2020 — Apr 2020 [monthly]
Recruiting
-
Nov 2018 — Feb 2020 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
For direct contact, visit the study record on ClinicalTrials.gov .